These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 22172705

  • 1. New thiazole carboxamides as potent inhibitors of Akt kinases.
    Chang S, Zhang Z, Zhuang X, Luo J, Cao X, Li H, Tu Z, Lu X, Ren X, Ding K.
    Bioorg Med Chem Lett; 2012 Jan 15; 22(2):1208-12. PubMed ID: 22172705
    [Abstract] [Full Text] [Related]

  • 2. Structural optimization elaborates novel potent Akt inhibitors with promising anticancer activity.
    Liu Y, Yin Y, Zhang Z, Li CJ, Zhang H, Zhang D, Jiang C, Nomie K, Zhang L, Wang ML, Zhao G.
    Eur J Med Chem; 2017 Sep 29; 138():543-551. PubMed ID: 28704757
    [Abstract] [Full Text] [Related]

  • 3. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R, Yang F, Chang SH, Tang J, Qin J, Feng GK, Ding K, Zhu XF.
    Mol Pharmacol; 2012 Aug 29; 82(2):189-98. PubMed ID: 22553359
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC, Li DD, Li QS, Lu X, Xiao ZP, Zhu HL.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5374-7. PubMed ID: 21802290
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt.
    Ko JH, Yeon SW, Ryu JS, Kim TY, Song EH, You HJ, Park RE, Ryu CK.
    Bioorg Med Chem Lett; 2006 Dec 01; 16(23):6001-5. PubMed ID: 16990001
    [Abstract] [Full Text] [Related]

  • 6. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors.
    Altıntop MD, Sever B, Akalın Çiftçi G, Özdemir A.
    Molecules; 2018 May 31; 23(6):. PubMed ID: 29857484
    [Abstract] [Full Text] [Related]

  • 7. 2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities.
    Tantak MP, Wang J, Singh RP, Kumar A, Shah K, Kumar D.
    Bioorg Med Chem Lett; 2015 Oct 01; 25(19):4225-31. PubMed ID: 26298501
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of N-(4-aminopyridin-2-yl)amides as B-Raf(V600E) inhibitors.
    Li X, Shen J, Tan L, Zhang Z, Gao D, Luo J, Cheng H, Zhou X, Ma J, Ding K, Lu X.
    Bioorg Med Chem Lett; 2016 Jun 15; 26(12):2760-2763. PubMed ID: 27155899
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
    Abdel-Maksoud MS, Kim MR, El-Gamal MI, Gamal El-Din MM, Tae J, Choi HS, Lee KT, Yoo KH, Oh CH.
    Eur J Med Chem; 2015 May 05; 95():453-63. PubMed ID: 25841200
    [Abstract] [Full Text] [Related]

  • 10. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
    Zeytün E, Altıntop MD, Sever B, Özdemir A, Ellakwa DE, Ocak Z, Ciftci HI, Otsuka M, Fujita M, Radwan MO.
    Anticancer Agents Med Chem; 2021 May 05; 21(9):1099-1109. PubMed ID: 32838725
    [Abstract] [Full Text] [Related]

  • 11. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.
    Diab S, Teo T, Kumarasiri M, Li P, Yu M, Lam F, Basnet SK, Sykes MJ, Albrecht H, Milne R, Wang S.
    ChemMedChem; 2014 May 05; 9(5):962-72. PubMed ID: 24677692
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.
    Zhang D, Ai J, Liang Z, Li C, Peng X, Ji Y, Jiang H, Geng M, Luo C, Liu H.
    Bioorg Med Chem; 2012 Sep 01; 20(17):5169-80. PubMed ID: 22863529
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis, cytotoxicity of new 4-arylidene curcumin analogues and their multi-functions in inhibition of both NF-κB and Akt signalling.
    Zuo Y, Huang J, Zhou B, Wang S, Shao W, Zhu C, Lin L, Wen G, Wang H, Du J, Bu X.
    Eur J Med Chem; 2012 Sep 01; 55():346-57. PubMed ID: 22889562
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH, Xiang L, Li X, Zhao TT, Zhang H, Zhou WP, Wang XM, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 May 01; 20(9):2789-95. PubMed ID: 22503364
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological evaluation of pyrazol-furan carboxamide analogues as novel Akt kinase inhibitors.
    Zhan W, Xu L, Dong X, Dong J, Yi X, Ma X, Qiu N, Li J, Yang B, Zhou Y, Hu Y.
    Eur J Med Chem; 2016 Jul 19; 117():47-58. PubMed ID: 27089211
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, in vitro antiproliferative evaluation and GSK-3β kinase inhibition of a new series of pyrimidin-4-one based amide conjugates.
    Khan I, Tantray MA, Hamid H, Sarwar Alam M, Sharma K, Kesharwani P.
    Bioorg Chem; 2022 Feb 19; 119():105512. PubMed ID: 34861627
    [Abstract] [Full Text] [Related]

  • 20. Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.
    Lapierre JM, Eathiraj S, Vensel D, Liu Y, Bull CO, Cornell-Kennon S, Iimura S, Kelleher EW, Kizer DE, Koerner S, Makhija S, Matsuda A, Moussa M, Namdev N, Savage RE, Szwaya J, Volckova E, Westlund N, Wu H, Schwartz B.
    J Med Chem; 2016 Jul 14; 59(13):6455-69. PubMed ID: 27305487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.